PubAg

Main content area

Botulinum neurotoxin subtype A2 enters neuronal cells faster than subtype A1

Author:
Pier, Christina L., Chen, Chen, Tepp, William H., Lin, Guangyun, Janda, Kim D., Barbieri, Joseph T., Pellett, Sabine, Johnson, Eric A.
Source:
FEBS letters 2011 v.585 no.1 pp. 199-206
ISSN:
0014-5793
Subject:
biopharmaceuticals, botulinum toxin, botulism, gangliosides, humans, models, natural toxicants, neurons, poisoning, therapeutics, toxicity
Abstract:
Botulinum neurotoxins (BoNTs), the causative agent of human botulism, are the most potent naturally occurring toxins known. BoNT/A1, the most studied BoNT, is also used as an important biopharmaceutical. In this study, the biological activity of BoNT/A1 is compared to that of BoNT/A2 using neuronal cell models. The data obtained indicate faster and increased intoxication of neuronal cells by BoNT/A2 than BoNT/A1, and that the mechanism underlying this increased toxicity is faster and more efficient cell entry that is independent of ganglioside binding. These results have important implications for the development of new BoNT based therapeutics and BoNT countermeasures.
Agid:
982832